SCHEMBL13259172

SCHEMBL13259172

C(#Cc1ccccc1)CN(CC#Cc1ccccc1)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 2/20 0.54
CYP3A4 P08684 3/20 0.47
CYP2C9 P11712 2/20 0.47
CYP2C19 P33261 2/20 0.47
CYP1A2 P05177 1/20 0.47
THPO P40225 1/20 0.47
TSHR P16473 3/20 0.45
BLM P54132 1/20 0.45
PMP22 Q01453 1/20 0.45
SIGMAR1 Q99720 1/20 0.43
APP P05067 1/20 0.42
ALDH1A1 P00352 2/20 0.41
KCNH2 Q12809 2/20 0.40
USP2 O75604 1/20 0.40
LMNA P02545 1/20 0.40
MAOA P21397 1/20 0.40
MAOB P27338 1/20 0.40
HTR2A P28223 1/20 0.40
SQLE Q14534 1/20 0.40
CNR2 P34972 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9731847 0.81 ALDH1A1 (0.48) PYCR1CYP3A4TSHRBLMALDH1A1
SCHEMBL46288 0.78 KCNH2 (0.58) PYCR1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL28486049 0.76 KCNH2 (0.61) PYCR1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL17188617 0.76 CYP3A4 (0.42) PYCR1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL26668490 0.76 PYCR1 (0.41) PYCR1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL29430122 0.74 PYCR1 (0.46) PYCR1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL3397750 0.73 CYP1A2 (0.58) CYP3A4CYP2C9CYP2C19CYP1A2THPO
SCHEMBL13259165 0.73 TSHR (0.42) PYCR1CYP3A4CYP2C19TSHRBLM
SCHEMBL19420119 0.73 PYCR1 (0.47) PYCR1CYP3A4CYP2C9CYP2C19CYP1A2
SCHEMBL13259183 0.72 MAOB (0.64) PYCR1CYP3A4CYP1A2TSHRBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100168441-A1 PROCESS FOR PRODUCTION OF SUBSTITUTED BENZENE NISSAN CHEMICAL INDUSTRIES, LTD. (JP) 2010-07-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100168441-A1 PROCESS FOR PRODUCTION OF SUBSTITUTED BENZENE MYB, KCNH2, INTS9 PYCR1 1638/4885CYP3A4 204/4885CYP2C9 382/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.